Artificial Intelligence in Cardiology Market Size & Analysis Report By Component (Hardware, Services), By Application (Stroke, CHD/CAD), By Region and Segment Forecasts, 2023 - 2030

Report Overview

The Artificial Intelligence in Cardiology Market was valued at 780.41 million in 2022 and expected to grow at CAGR of 35.1% over forecast period.

The artificial intelligence in cardiology market is being driven by several key factors, including the rising prevalence of cardiovascular diseases such as heart disease and stroke, which necessitate more efficient and accurate diagnostic and treatment tools. AI technologies have the potential to analyze massive amounts of medical data, such as complex imaging and patient records, allowing for earlier and more precise disease detection. Furthermore, the demand for personalized treatment plans and risk assessment tools corresponds to AI's ability to tailor interventions based on individual patient data.

Regulatory bodies are increasingly recognizing AI-driven solutions, which has resulted in the creation of supportive frameworks. Furthermore, the incorporation of AI into healthcare systems aims to improve clinical decision-making and patient outcomes, thereby stimulating investment and innovation in cardiology.

Component Outlook

Based on Component, the Artificial Intelligence in Cardiology Market is segmented in Hardware, Services. Services segment accounted for largest share in 2022. The growing demand for more efficient, accurate, and data-driven solutions in cardiovascular healthcare is driving the software-driven artificial intelligence in cardiology market. AI software can analyze massive amounts of medical data, such as complex imaging and patient records, allowing for earlier disease detection, risk assessment, and personalized treatment strategies.

Cardiovascular diagnostic and treatment processes rely on intensive computational tasks like high-resolution imaging analysis and real-time monitoring, which necessitate advanced hardware solutions. As artificial intelligence (AI) continues to play an important role in improving the accuracy and efficiency of cardiology diagnostics and treatments, there is a growing demand for dedicated AI hardware to support these tasks. Furthermore, advancements in specialized hardware, such as GPUs, ASICs, and accelerators, are assisting in the acceleration of AI model training and inference, making it a critical driver in the hardware-centric artificial intelligence market for cardiology.

Application Outlook

Based on Application, Artificial Intelligence in Cardiology Market is segmented into Stroke, CHD/CAD. Coronary artery disease (CAD) accounted for largest share in 2022.  Several key factors drive the artificial intelligence market in cardiology, with a focus on coronary artery disease (CAD). CAD is a leading cause of heart disease, and the incorporation of AI has the potential to significantly improve early detection, risk assessment, and personalized treatment plans, thereby addressing a critical healthcare need. AI can analyze complex medical imaging, such as angiograms and CT scans, to help identify CAD-related blockages.

The artificial intelligence market in cardiology, specifically in stroke management, is being driven by the urgent need for faster and more accurate stroke diagnosis and treatment, as strokes are a major cause of disability and mortality. The ability of AI to analyze medical imaging, such as CT and MRI scans, allows for the rapid identification of stroke patterns, allowing for faster intervention and better patient outcomes. Furthermore, AI-powered algorithms can aid in the prediction of stroke risk in at-risk populations, facilitating preventive strategies.

Regional Outlook

North America is emerged as leading market for Artificial Intelligence in Cardiology Market in 2022. North American artificial intelligence in cardiology market is being driven by several key factors, including the region's high prevalence of cardiovascular diseases and robust healthcare infrastructure. Because heart disease remains a leading cause of morbidity and mortality, there is an urgent need for more efficient and accurate diagnostic and treatment tools, which AI can provide. The region's advanced technology adoption, access to large amounts of healthcare data, and strong emphasis on research and innovation all contribute to the growth of AI in cardiology.

With a growing demand for high-quality and efficient cardiac care, AI technologies play an important role in improving diagnosis and treatment in a region where healthcare professionals are in short supply. The COVID-19 pandemic has accelerated the adoption of digital health and telemedicine, fueling demand for AI applications in cardiology. Furthermore, supportive government initiatives, increased R&D efforts, and a thriving tech industry are driving innovation in the Asia Pacific region, positioning it as a key driver in the AI cardiology market.

Recent Key Developments in Artificial Intelligence in Cardiology Market

• In October 2023, the Icahn School of Medicine at Mount Sinai announced partnership with Chiba Institute of Technology in Japan to research on cure for Cardiovascular dieses using artificial intelligence

• In October 2023, GE Healthcare announced launch of enhanced venue family point of care ultrasound systems. AI-powered technology will increase access to scans by allowing a broader range of healthcare providers to perform cardiac exams at the point of care with real-time guidance.

• In November 2022, Viz.ai launched cardiology software suite called Viz Cardio Suite. The software will be used to improve patient access to cardiovascular treatments. The software recognizes patients with specific cardiovascular diseases and notifies the appropriate clinician so that treatment can be initiated and monitored.

Artificial Intelligence in Cardiology Market Report Scope

Artificial Intelligence in Cardiology Market Segmentation

Component Outlook (Revenue, USD Million, 2018 - 2030)

• Hardware
• Services

End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Stroke
• CHD/CAD

Artificial Intelligence in Cardiology Market, Regional Outlook

North America

• U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• Spain
• Russia
• France
• Italy

Asia Pacific

• China
• Japan
• India
• South Korea
• Australia

CSA

• Brazil
• Argentina

MEA

• UAE
• Saudi Arabia
• South Africa